Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $21,157 - $35,151
-639 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $25,417 - $36,126
-449 Reduced 41.27%
639 $40,000
Q1 2021

May 14, 2021

BUY
$86.23 - $125.19 $35,181 - $51,077
408 Added 60.0%
1,088 $101,000
Q4 2020

Feb 10, 2021

SELL
$79.17 - $111.47 $475 - $668
-6 Reduced 0.87%
680 $61,000
Q3 2020

Nov 13, 2020

BUY
$81.91 - $134.94 $21,951 - $36,163
268 Added 64.11%
686 $71,000
Q2 2020

Aug 11, 2020

BUY
$54.33 - $89.52 $22,709 - $37,419
418 New
418 $33,000
Q3 2019

Nov 13, 2019

SELL
$40.6 - $57.2 $5,805 - $8,179
-143 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $1,317 - $1,777
33 Added 30.0%
143 $7,000
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $916 - $1,257
19 Added 20.88%
110 $6,000
Q4 2018

Feb 13, 2019

SELL
$55.63 - $73.24 $3,393 - $4,467
-61 Reduced 40.13%
91 $5,000
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $728 - $931
-14 Reduced 8.43%
152 $10,000
Q2 2018

Aug 01, 2018

SELL
$48.33 - $55.64 $434 - $500
-9 Reduced 5.14%
166 $8,000
Q1 2018

May 16, 2018

BUY
$44.44 - $54.39 $266 - $326
6 Added 3.55%
175 $9,000
Q4 2017

Feb 13, 2018

BUY
$37.77 - $47.75 $6,307 - $7,974
167 Added 8350.0%
169 $8,000
Q1 2017

Sep 15, 2017

SELL
N/A
-14 Reduced 87.5%
2 $0
Q4 2016

Sep 15, 2017

BUY
N/A
14 Added 700.0%
16 $1,000
Q1 2016

Sep 15, 2017

SELL
N/A
-7,335 Reduced 99.97%
2 $0
Q4 2015

Sep 15, 2017

BUY
N/A
7,337
7,337 $294,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $504M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.